Navigation Links
Evolving Market Access in the APAC Region, a New Xtalks Life Sciences Webinar
Date:3/28/2013

Toronto, Canada (PRWEB) March 28, 2013

As the pharmaceutical industry in the West is being challenged with austerity and increasing pricing pressure, companies have started looking to diversify their portfolios through emerging markets. The countries within emerging markets are highly diverse and business models need to be locally tailored to ensure success.

The aim of this webinar is to cover market access related issues in the Asia Pacific region, including Japan and China, representing the world’s second and third largest pharmaceutical markets. South Korea and Taiwan, also major reimbursement markets as well as innovators in biologics and specialty products, will also be discussed.

This session will cover:

Ongoing healthcare reform in China and its implication on access

  • Top level regulatory requirement overview
  • Market access in China: What are Reimbursement Drug List and Essential Drug List and how are prices set?
  • Pricing trends
  • Healthcare reform bill and the impact on distribution channels
  • How to address the affordability issue?

Pricing trends and price premiums in Japan

  • Pricing and access principles
  • Reward for innovation
  • The utility of health economics

HTA in the APAC region:

  • The adaptation of Health Technology Assessment (HTA) in Japan and China
  • The impact of HTA on reimbursement, pricing and access in S Korea and Taiwan

For more information about this event or to register, visit: http://xtks.in/ZnKQUb.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Zayeeta Dasgupta, M.Sc in Life Science and Business Management
1- (416) 977-6555 ext. 260

Read the full story at http://www.prweb.com/releases/2013/3/prweb10557718.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. NDIS Approval of Promega PowerPlex® Fusion System Assists Laboratories in Meeting Evolving Standards
2. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
9. GeneLink Marketing Efforts Poised to Show Results
10. Animal Biotechnology - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
Breaking Biology Technology:
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):